Stemcells (STEM) Posts Q1 Loss of 17c/Share

Stemcells (NASDAQ: STEM) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $284 thousand versus the consensus estimate of $290 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Conmed (CNMD) Tops Q2 EPS by 27c ; Offers Guidance
• Sonos (SONO) Tops Q3 EPS by 29c
• Meta Platforms (META) Misses Q2 EPS by 99c; offers guidance